4/A: SOPHIA GENETICS SA: Insider Ownership Update

SOPHIA GENETICS SA files Form 4/A to amend prior reporting of beneficial ownership, correcting the number of ordinary shares held by Chief Legal Officer Daan van Well.

Summary

• This filing is an amendment (Form 4/A) to a previous Form 4 filed on April 3, 2026.
• The amendment corrects the reported amount of ordinary shares beneficially owned by Daan van Well, Chief Legal Officer.
• The corrected amount of ordinary shares beneficially owned is 358,774, an increase from the previously reported 97,536.
• The filing also details a restricted stock unit (RSU) grant of 97,536 ordinary shares made under the Issuer's 2021 Equity Incentive Plan.
• These RSUs vest over time, with 25% vesting on April 2, 2027, and the remainder vesting quarterly through April 2, 2030.
• Additionally, a share option for 142,216 ordinary shares with an exercise price of $5.04 was granted.
• This option vests 25% on April 2, 2027, and the remaining 75% vests in equal monthly installments through April 2, 2030.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this filing as neutral, primarily an administrative correction of ownership data with standard equity grant disclosures.

Positives

• Correction of beneficial ownership amount provides a more accurate representation of insider holdings.
• Grant of RSUs and share options indicates continued incentive alignment for key management personnel.
• Vesting schedules for RSUs and options are spread over several years, promoting long-term commitment.

Negatives

• The initial error in reporting the beneficial ownership amount could raise minor concerns about internal reporting accuracy.

Risks

• Vesting of RSUs and options is contingent on continued service, meaning potential forfeiture if the reporting person leaves the company.
• The value of the granted equity is subject to the future performance and stock price of SOPHiA GENETICS SA.

Future Outlook

The filing does not contain forward-looking statements or guidance. It primarily serves to correct previously reported ownership data and detail equity grants with future vesting schedules.

Management Comments

• The filing is an amendment to correct an inadvertent error in reporting the amount of ordinary shares beneficially owned.

Industry Context

StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions. This amendment highlights the importance of accurate reporting of beneficial ownership, a key aspect of corporate governance and transparency in the biotechnology and healthcare technology sectors.

Corporate Governance

Stakeholder Impact

• Shareholders: Increased transparency regarding the accurate number of shares held by a key executive.
• Employees: Reinforces the company's use of equity incentives to retain talent.
• Management: Highlights the importance of accurate and timely SEC filings.

Next Steps

• Continued service by Daan van Well to meet vesting requirements for RSUs and options.
• Future disclosures on any further changes in beneficial ownership by insiders.

Key Dates

Keywords

SOPHIA GENETICS SA, Form 4/A, Insider Trading, Beneficial Ownership, Restricted Stock Units, Stock Options, Equity Incentive Plan, Chief Legal Officer, SEC Filing